Skip to main content
. Author manuscript; available in PMC: 2022 Mar 18.
Published in final edited form as: Transl Res. 2021 Feb 19;233:77–91. doi: 10.1016/j.trsl.2021.02.009

Table 2.

Diagnostic performance of the determination of the three complement C4-derived fragments in plasma samples from early-stage lung cancer

Diagnostic parameters* C4d-containing fragments C4d C4c
Sensitivity (%) 92 (79–98) 79(64–91) 72 (55–85)
Specificity (%) 44 (28–60) 82 (66–92) 95 (83–99)
Accuracy (%) 68 (56–78) 81 (70–89) 83 (73–91)
Positive predictive value (%) 62 (55–69) 82 (69–90) 93 (78–98)
Negative predictive value (%) 85 (64–95) 80 (68–88) 77 (67–85)
Positive likelihood ratio 1.64(1.22–2.19) 4.43 (2.22–8.83) 14.00 (3.58–54.78)
Negative likelihood ratio 0.18(0.06–0.55) 0.25(0.13–0.47) 0.30(0.18–0.49)
*

Diagnostic parameters were calculated using the cut-off that provides the maximum Youden index. 95% CIs are also shown.